Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Chemistry, Manufacturing and Controls (CMC) Regulatory Landscape in Emerging Markets

Session Chair(s)

T.  Venkateshwaran, PhD

T. Venkateshwaran, PhD

Vice President and Global Head CMC Biologics, Medical Devices and Comb

Merck & Co., Inc., United States

This session will discuss the challenges observed due to the changing regulations in emerging markets.

Learning Objective : Discuss the CMC regulatory challenges involved with the drug approval process in emerging markets.

Speaker(s)

Chi-Wan  Chen, PhD

Regulatory Landscape in China– Challenges and Opportunities

Chi-Wan Chen, PhD

Pfizer, Inc., United States

Rebecca E. Thomas, MS

An Industry Perspective of the Approval Process in Russia

Rebecca E. Thomas, MS

Bekki Thomas Consulting, LLC, United States

Owner

Sampat  Singhvi

Latin America: Emerging Regulations - Are They a Challenge or an Opportunity?

Sampat Singhvi

Takeda Pharmaceutical International, United States

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.